RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Historical Holders from Q2 2025 to Q3 2025

Symbol
RAPT on Nasdaq
Type / Class
Equity / Common Stock $0.0001 par value per share
Shares outstanding
16,532,679
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
13,622,837
Holdings value
$351,333,277
% of all portfolios
0%
Number of holders
60
Number of buys
32
Number of sells
-24
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ForGrowth III PA B.V. 7.4% $47,291,008 1,833,333 ForGrowth III PA B.V. 23 Oct 2025
Redmile Group, LLC 9.9% $14,934,463 1,765,303 Redmile Group, LLC 30 Jun 2025
VANGUARD GROUP INC 4.2% $17,958,239 696,188 The Vanguard Group 30 Sep 2025
Nantahala Capital Management, LLC 3.77% -33% $16,074,692 -$8,467,788 623,282 -35% Nantahala Capital Management, LLC 30 Sep 2025

Institutional Holders of RAPT Therapeutics, Inc. - Common Stock $0.0001 par value per share (RAPT)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 13,622,837 $351,333,277 +$19,238,054 $25.79 60
2025 Q2 15,619,662 $124,884,006 +$124,882,925 $8 45